Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Extra expenses call for smart tweaks. This intro covers simple ways to adjust your budget to accommodate additional costs.
12,516 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
Marvell Technology rides AI tailwinds into a breakout, delivering record quarterly momentum and a growing pipeline of...
Long-dated U.S. Treasuries saw muted appetite from investors as inflation remains stubborn and energy risks persist. ...
A notable fund exit from Sprinklr during a year of rapid AI adoption offers real-world lessons for investors. Here’s ...
A fresh inflation outlook from the FED just arrived in May, and markets moved on the news. This article breaks down w...
Tesla commands a large slug of XLY, giving the fund a distinct risk/reward profile compared with VCR. In the past fiv...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...
Chewy, crowned america’s best brand america’s in a 2026 reputation poll, faces a sharp stock drop as brand strength f...
Century DeAnna Realty capped a five-year growth sprint with a 110% rise in transactions, leveraging culture-driven M&...
A popular income play is facing questions as rate volatility persists. The Amplify fund blends high-quality dividends...
The SpaceX IPO is stirring big hype, but not every spark is a signal to buy. This guide explains the worst reason spa...